BOENNING & SCATTERGOOD, INC. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOENNING & SCATTERGOOD, INC. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,295
-99.7%
53,475
+76.7%
0.21%
+105.9%
Q3 2022$495,000
+15.4%
30,260
-0.7%
0.10%
+24.7%
Q2 2022$429,000
-66.9%
30,460
-43.0%
0.08%
-61.1%
Q1 2022$1,295,000
+3.8%
53,4750.0%0.21%
+4.5%
Q4 2021$1,248,000
+39.6%
53,475
-0.7%
0.20%
+26.8%
Q3 2021$894,000
-37.7%
53,875
-8.5%
0.16%
-37.2%
Q2 2021$1,436,000
+64.3%
58,875
+73.8%
0.25%
+50.6%
Q1 2021$874,000
-51.7%
33,8750.0%0.17%
-56.8%
Q4 2020$1,811,000
+29.6%
33,8750.0%0.38%
+14.6%
Q3 2020$1,397,000
-13.9%
33,875
+1.2%
0.34%
-22.6%
Q2 2020$1,623,000
+14.8%
33,4750.0%0.43%
-11.3%
Q1 2020$1,414,000
+11.7%
33,475
+13.1%
0.49%
+49.7%
Q4 2019$1,266,000
+32.3%
29,600
+11.3%
0.33%
+17.7%
Q3 2019$957,000
+34.6%
26,6000.0%0.28%
+33.2%
Q2 2019$711,000
-48.7%
26,600
-48.5%
0.21%
-49.9%
Q1 2019$1,387,000
+74.0%
51,650
+4.8%
0.42%
+49.3%
Q4 2018$797,000
-17.1%
49,300
+6.5%
0.28%
-8.9%
Q3 2018$961,000
+34.8%
46,300
-0.9%
0.30%
+30.3%
Q2 2018$713,00046,7000.23%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders